These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit. Yee GC; McGuire TR; Gmur DJ; Lennon TP; Deeg HJ Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods. Yee GC; Kennedy MS; Storb R; Thomas ED Transplantation; 1984 Nov; 38(5):511-3. PubMed ID: 6388073 [TBL] [Abstract][Full Text] [Related]
5. Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients. Yee GC; Lennon TP; Gmur DJ; Kennedy MS; Deeg HJ Transplant Proc; 1987 Feb; 19(1 Pt 2):1704-5. PubMed ID: 3274407 [No Abstract] [Full Text] [Related]
6. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation. Yee GC; Self SG; McGuire TR; Carlin J; Sanders JE; Deeg HJ N Engl J Med; 1988 Jul; 319(2):65-70. PubMed ID: 3288872 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937 [TBL] [Abstract][Full Text] [Related]
8. [Cyclosporine in allogeneic bone marrow transplantation in children]. Kojima S; Fukuda M; Horibe K; Matsuyama K Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658 [No Abstract] [Full Text] [Related]
9. [Immunosuppressive-associated encephalopathy in bone marrow transplant recipients]. Ohta K; Yoritaka A; Sakamaki H; Kishida S; No To Shinkei; 2004 May; 56(5):395-401. PubMed ID: 15279197 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia. Werner EJ; Stout RD; Valdez LP; Harris RE Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621 [TBL] [Abstract][Full Text] [Related]
12. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients. Choi JS; Lee SH; Chung SJ; Yoo KH; Sung KW; Koo HH Bone Marrow Transplant; 2006 Jul; 38(1):29-35. PubMed ID: 16715103 [TBL] [Abstract][Full Text] [Related]
13. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease. Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942 [No Abstract] [Full Text] [Related]
15. Parenteral nutrition in marrow transplant recipients after discharge from the hospital. Lenssen P; Moe GL; Cheney CL; Aker SN; Deeg HJ Exp Hematol; 1983 Nov; 11(10):974-81. PubMed ID: 6420178 [TBL] [Abstract][Full Text] [Related]
16. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553 [TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656 [TBL] [Abstract][Full Text] [Related]